ID   SCO2_HUMAN              Reviewed;         266 AA.
AC   O43819; Q3T1B5; Q9UK87;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 3.
DT   28-JAN-2026, entry version 218.
DE   RecName: Full=Cytochrome c oxidase assembly factor SCO2 {ECO:0000305};
DE   Flags: Precursor;
GN   Name=SCO2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS MC4DN2 LYS-140 AND PHE-225.
RX   PubMed=10545952; DOI=10.1038/15513;
RA   Papadopoulou L.C., Sue C.M., Davidson M.M., Tanji K., Nishino I.,
RA   Sadlock J.E., Krishna S., Walker W., Selby J., Glerum D.M., Van Coster R.,
RA   Lyon G., Scalais E., Lebel R., Kaplan P., Shanske S., De Vivo D.C.,
RA   Bonilla E., Hirano M., DiMauro S., Schon E.A.;
RT   "Fatal infantile cardioencephalomyopathy with COX deficiency and mutations
RT   in SCO2, a COX assembly gene.";
RL   Nat. Genet. 23:333-337(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Monocyte;
RX   PubMed=12529303; DOI=10.1101/gr.695703;
RA   Collins J.E., Goward M.E., Cole C.G., Smink L.J., Huckle E.J., Knowles S.,
RA   Bye J.M., Beare D.M., Dunham I.;
RT   "Reevaluating human gene annotation: a second-generation analysis of
RT   chromosome 22.";
RL   Genome Res. 13:27-36(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT PRO-20.
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY, AND SUBUNIT.
RX   PubMed=15229189; DOI=10.1093/hmg/ddh197;
RA   Leary S.C., Kaufman B.A., Pellecchia G., Guercin G.H., Mattman A.,
RA   Jaksch M., Shoubridge E.A.;
RT   "Human SCO1 and SCO2 have independent, cooperative functions in copper
RT   delivery to cytochrome c oxidase.";
RL   Hum. Mol. Genet. 13:1839-1848(2004).
RN   [6]
RP   FUNCTION, AND CHARACTERIZATION OF VARIANT MC4DN2 LYS-140.
RX   PubMed=17189203; DOI=10.1016/j.cmet.2006.12.001;
RA   Leary S.C., Cobine P.A., Kaufman B.A., Guercin G.H., Mattman A., Palaty J.,
RA   Lockitch G., Winge D.R., Rustin P., Horvath R., Shoubridge E.A.;
RT   "The human cytochrome c oxidase assembly factors SCO1 and SCO2 have
RT   regulatory roles in the maintenance of cellular copper homeostasis.";
RL   Cell Metab. 5:9-20(2007).
RN   [7]
RP   FUNCTION, AND CHARACTERIZATION OF VARIANT MC4DN2 LYS-140.
RX   PubMed=19336478; DOI=10.1093/hmg/ddp158;
RA   Leary S.C., Sasarman F., Nishimura T., Shoubridge E.A.;
RT   "Human SCO2 is required for the synthesis of CO II and as a thiol-
RT   disulphide oxidoreductase for SCO1.";
RL   Hum. Mol. Genet. 18:2230-2240(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   INTERACTION WITH COX20.
RX   PubMed=24403053; DOI=10.1093/hmg/ddu003;
RA   Bourens M., Boulet A., Leary S.C., Barrientos A.;
RT   "Human COX20 cooperates with SCO1 and SCO2 to mature COX2 and promote the
RT   assembly of cytochrome c oxidase.";
RL   Hum. Mol. Genet. 23:2901-2913(2014).
RN   [10]
RP   INTERACTION WITH COA6, CHARACTERIZATION OF VARIANT MYP6 HIS-114, AND
RP   CHARACTERIZATION OF VARIANT MC4DN2 TRP-171.
RX   PubMed=25959673; DOI=10.1016/j.cmet.2015.04.012;
RA   Pacheu-Grau D., Bareth B., Dudek J., Juris L., Voegtle F.N., Wissel M.,
RA   Leary S.C., Dennerlein S., Rehling P., Deckers M.;
RT   "Cooperation between COA6 and SCO2 in COX2 maturation during cytochrome c
RT   oxidase assembly links two mitochondrial cardiomyopathies.";
RL   Cell Metab. 21:823-833(2015).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   INTERACTION WITH COX16.
RX   PubMed=29381136; DOI=10.7554/elife.32572;
RA   Aich A., Wang C., Chowdhury A., Ronsoer C., Pacheu-Grau D.,
RA   Richter-Dennerlein R., Dennerlein S., Rehling P.;
RT   "COX16 promotes COX2 metallation and assembly during respiratory complex IV
RT   biogenesis.";
RL   Elife 7:0-0(2018).
RN   [13]
RP   IDENTIFICATION IN A COMPLEX WITH TMEM177; COA6; MT-CO2; COX20; COX18 AND
RP   SCO1, AND INTERACTION WITH TMEM177 AND COX20.
RX   PubMed=29154948; DOI=10.1016/j.bbamcr.2017.11.010;
RA   Lorenzi I., Oeljeklaus S., Aich A., Ronsoer C., Callegari S., Dudek J.,
RA   Warscheid B., Dennerlein S., Rehling P.;
RT   "The mitochondrial TMEM177 associates with COX20 during COX2 biogenesis.";
RL   Biochim. Biophys. Acta 1865:323-333(2017).
RN   [14]
RP   INTERACTION WITH COX20.
RX   PubMed=28330871; DOI=10.1074/jbc.m117.778514;
RA   Bourens M., Barrientos A.;
RT   "Human mitochondrial cytochrome c oxidase assembly factor COX18 acts
RT   transiently as a membrane insertase within the subunit 2 maturation
RT   module.";
RL   J. Biol. Chem. 292:7774-7783(2017).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=35750769; DOI=10.1038/s41467-022-31413-1;
RA   Nyvltova E., Dietz J.V., Seravalli J., Khalimonchuk O., Barrientos A.;
RT   "Coordination of metal center biogenesis in human cytochrome c oxidase.";
RL   Nat. Commun. 13:3615-3615(2022).
RN   [16]
RP   STRUCTURE BY NMR OF 100-266 ALONE AND IN COMPLEX WITH COPPER, AND
RP   COPPER-BINDING SITES.
RX   PubMed=17850752; DOI=10.1016/j.str.2007.07.011;
RA   Banci L., Bertini I., Ciofi-Baffoni S., Gerothanassis I.P., Leontari I.,
RA   Martinelli M., Wang S.;
RT   "A structural characterization of human SCO2.";
RL   Structure 15:1132-1140(2007).
RN   [17]
RP   VARIANTS MC4DN2 SER-193 AND THR-258.
RX   PubMed=26741492; DOI=10.1371/journal.pgen.1005679;
RA   Kohda M., Tokuzawa Y., Kishita Y., Nyuzuki H., Moriyama Y., Mizuno Y.,
RA   Hirata T., Yatsuka Y., Yamashita-Sugahara Y., Nakachi Y., Kato H.,
RA   Okuda A., Tamaru S., Borna N.N., Banshoya K., Aigaki T., Sato-Miyata Y.,
RA   Ohnuma K., Suzuki T., Nagao A., Maehata H., Matsuda F., Higasa K.,
RA   Nagasaki M., Yasuda J., Yamamoto M., Fushimi T., Shimura M.,
RA   Kaiho-Ichimoto K., Harashima H., Yamazaki T., Mori M., Murayama K.,
RA   Ohtake A., Okazaki Y.;
RT   "A comprehensive genomic analysis reveals the genetic landscape of
RT   mitochondrial respiratory chain complex deficiencies.";
RL   PLoS Genet. 12:E1005679-E1005679(2016).
RN   [18]
RP   VARIANTS MC4DN2 LYS-140 AND TRP-171.
RX   PubMed=10749987; DOI=10.1093/hmg/9.5.795;
RA   Jaksch M., Ogilvie I., Yao J., Kortenhaus G., Bresser H.G., Gerbitz K.D.,
RA   Shoubridge E.A.;
RT   "Mutations in SCO2 are associated with a distinct form of hypertrophic
RT   cardiomyopathy and cytochrome c oxidase deficiency.";
RL   Hum. Mol. Genet. 9:795-801(2000).
RN   [19]
RP   VARIANT MC4DN2 LYS-140.
RX   PubMed=11673586; DOI=10.1212/wnl.57.8.1440;
RA   Jaksch M., Horvath R., Horn N., Auer D.P., Macmillan C., Peters J.,
RA   Gerbitz K.D., Kraegeloh-Mann I., Muntau A., Karcagi V., Kalmanchey R.,
RA   Lochmuller H., Shoubridge E.A., Freisinger P.;
RT   "Homozygosity (E140K) in SCO2 causes delayed infantile onset of
RT   cardiomyopathy and neuropathy.";
RL   Neurology 57:1440-1446(2001).
RN   [20]
RP   VARIANTS MC4DN2 TYR-133 AND LYS-140.
RX   PubMed=14994243; DOI=10.1002/ajmg.a.20466;
RA   Tarnopolsky M.A., Bourgeois J.M., Fu M.H., Kataeva G., Shah J., Simon D.K.,
RA   Mahoney D., Johns D., MacKay N., Robinson B.H.;
RT   "Novel SCO2 mutation (G1521A) presenting as a spinal muscular atrophy type
RT   I phenotype.";
RL   Am. J. Med. Genet. A 125A:310-314(2004).
RN   [21]
RP   VARIANT PRO-20, AND VARIANT MC4DN2 SER-193.
RX   PubMed=19353847; DOI=10.5414/npp28143;
RA   Mobley B.C., Enns G.M., Wong L.J., Vogel H.;
RT   "A novel homozygous SCO2 mutation, p.G193S, causing fatal infantile
RT   cardioencephalomyopathy.";
RL   Clin. Neuropathol. 28:143-149(2009).
RN   [22]
RP   VARIANTS MYP6 HIS-114; LYS-140 AND VAL-259.
RX   PubMed=23643385; DOI=10.1016/j.ajhg.2013.04.005;
RA   Tran-Viet K.N., Powell C., Barathi V.A., Klemm T., Maurer-Stroh S.,
RA   Limviphuvadh V., Soler V., Ho C., Yanovitch T., Schneider G., Li Y.J.,
RA   Nading E., Metlapally R., Saw S.M., Goh L., Rozen S., Young T.L.;
RT   "Mutations in SCO2 are associated with autosomal-dominant high-grade
RT   myopia.";
RL   Am. J. Hum. Genet. 92:820-826(2013).
RN   [23]
RP   VARIANTS MYP6 TRP-112 AND TRP-120.
RX   PubMed=25525168; DOI=10.1167/iovs.14-14850;
RA   Jiang D., Li J., Xiao X., Li S., Jia X., Sun W., Guo X., Zhang Q.;
RT   "Detection of mutations in LRPAP1, CTSH, LEPREL1, ZNF644, SLC39A5, and SCO2
RT   in 298 families with early-onset high myopia by exome sequencing.";
RL   Invest. Ophthalmol. Vis. Sci. 56:339-345(2015).
CC   -!- FUNCTION: Copper metallochaperone essential for the synthesis and
CC       maturation of cytochrome c oxidase subunit II (MT-CO2/COX2); together
CC       with SCO1, facilitates the incorporation of copper into the Cu(A) site
CC       of MT-CO2/COX2 (PubMed:15229189, PubMed:17189203, PubMed:19336478,
CC       PubMed:35750769). Could also act as a thiol-disulfide oxidoreductase to
CC       regulate the redox state of the cysteines in SCO1 during maturation of
CC       MT-CO2/COX2 (PubMed:19336478). {ECO:0000269|PubMed:15229189,
CC       ECO:0000269|PubMed:17189203, ECO:0000269|PubMed:19336478,
CC       ECO:0000269|PubMed:35750769}.
CC   -!- SUBUNIT: Homodimer (PubMed:15229189). Interacts with COA6
CC       (PubMed:25959673). Found in a complex with TMEM177, COX20, COA6, MT-
CC       CO2/COX2, COX18 and SCO1 (PubMed:29154948). Interacts with TMEM177 in a
CC       COX20-dependent manner (PubMed:29154948). Interacts with COX20 in a MT-
CC       CO2/COX2- and COX18-dependent manner (PubMed:24403053, PubMed:28330871,
CC       PubMed:29154948). Interacts with COX16 (PubMed:29381136).
CC       {ECO:0000269|PubMed:15229189, ECO:0000269|PubMed:24403053,
CC       ECO:0000269|PubMed:25959673, ECO:0000269|PubMed:28330871,
CC       ECO:0000269|PubMed:29154948, ECO:0000269|PubMed:29381136}.
CC   -!- INTERACTION:
CC       O43819; Q9UHD4: CIDEB; NbExp=3; IntAct=EBI-357012, EBI-7062247;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000269|PubMed:15229189, ECO:0000269|PubMed:35750769}; Single-pass
CC       membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DISEASE: Mitochondrial complex IV deficiency, nuclear type 2 (MC4DN2)
CC       [MIM:604377]: An autosomal recessive, severe mitochondrial disorder
CC       characterized by hypotonia, global developmental delay, hypertrophic
CC       cardiomyopathy, lactic acidosis, gliosis, and neuronal loss in basal
CC       ganglia, brainstem and spinal cord. Serum lactate is increased, and
CC       laboratory studies show decreased mitochondrial complex IV protein and
CC       activity levels in various tissues, including heart and skeletal
CC       muscle. Most patients die in infancy of cardiorespiratory failure.
CC       {ECO:0000269|PubMed:10545952, ECO:0000269|PubMed:10749987,
CC       ECO:0000269|PubMed:11673586, ECO:0000269|PubMed:14994243,
CC       ECO:0000269|PubMed:17189203, ECO:0000269|PubMed:19336478,
CC       ECO:0000269|PubMed:19353847, ECO:0000269|PubMed:25959673,
CC       ECO:0000269|PubMed:26741492}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Myopia 6 (MYP6) [MIM:608908]: A refractive error of the eye,
CC       in which parallel rays from a distant object come to focus in front of
CC       the retina, vision being better for near objects than for far.
CC       {ECO:0000269|PubMed:23643385, ECO:0000269|PubMed:25525168,
CC       ECO:0000269|PubMed:25959673}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the SCO1/2 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF177385; AAF05313.1; -; Genomic_DNA.
DR   EMBL; AL021683; CAA16671.1; -; mRNA.
DR   EMBL; CR456569; CAG30455.1; -; mRNA.
DR   EMBL; BC102024; AAI02025.1; -; mRNA.
DR   EMBL; BC102025; AAI02026.1; -; mRNA.
DR   CCDS; CCDS14095.1; -.
DR   RefSeq; NP_001162580.1; NM_001169109.2.
DR   RefSeq; NP_001162581.1; NM_001169110.1.
DR   RefSeq; NP_001162582.1; NM_001169111.2.
DR   RefSeq; NP_005129.2; NM_005138.3.
DR   PDB; 2RLI; NMR; -; A=100-266.
DR   PDBsum; 2RLI; -.
DR   AlphaFoldDB; O43819; -.
DR   BMRB; O43819; -.
DR   SMR; O43819; -.
DR   BioGRID; 115317; 140.
DR   DIP; DIP-46088N; -.
DR   FunCoup; O43819; 1048.
DR   IntAct; O43819; 68.
DR   MINT; O43819; -.
DR   STRING; 9606.ENSP00000444433; -.
DR   GlyGen; O43819; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O43819; -.
DR   PhosphoSitePlus; O43819; -.
DR   SwissPalm; O43819; -.
DR   BioMuta; SCO2; -.
DR   jPOST; O43819; -.
DR   MassIVE; O43819; -.
DR   PaxDb; 9606-ENSP00000444433; -.
DR   PeptideAtlas; O43819; -.
DR   ProteomicsDB; 49182; -.
DR   Pumba; O43819; -.
DR   Antibodypedia; 78977; 167 antibodies from 31 providers.
DR   DNASU; 9997; -.
DR   Ensembl; ENST00000252785.3; ENSP00000252785.3; ENSG00000284194.4.
DR   Ensembl; ENST00000395693.8; ENSP00000379046.4; ENSG00000284194.4.
DR   Ensembl; ENST00000535425.5; ENSP00000444242.1; ENSG00000284194.4.
DR   Ensembl; ENST00000543927.6; ENSP00000444433.1; ENSG00000284194.4.
DR   GeneID; 9997; -.
DR   KEGG; hsa:9997; -.
DR   MANE-Select; ENST00000395693.8; ENSP00000379046.4; NM_005138.3; NP_005129.2.
DR   UCSC; uc003blz.5; human.
DR   AGR; HGNC:10604; -.
DR   ClinPGx; PA35013; -.
DR   CTD; 9997; -.
DR   DisGeNET; 9997; -.
DR   GeneCards; SCO2; -.
DR   GeneReviews; SCO2; -.
DR   HGNC; HGNC:10604; SCO2.
DR   HPA; ENSG00000284194; Low tissue specificity.
DR   MalaCards; SCO2; -.
DR   MIM; 604272; gene.
DR   MIM; 604377; phenotype.
DR   MIM; 608908; phenotype.
DR   Orphanet; 521411; Autosomal recessive axonal Charcot-Marie-Tooth disease due to copper metabolism defect.
DR   Orphanet; 1561; Fatal infantile cytochrome C oxidase deficiency.
DR   Orphanet; 98619; Rare isolated myopia.
DR   VEuPathDB; HostDB:ENSG00000284194; -.
DR   eggNOG; KOG2792; Eukaryota.
DR   GeneTree; ENSGT00390000004323; -.
DR   HOGENOM; CLU_050131_0_3_1; -.
DR   InParanoid; O43819; -.
DR   OMA; YYNRMKS; -.
DR   OrthoDB; 76676at2759; -.
DR   PAN-GO; O43819; 1 GO annotation based on evolutionary models.
DR   PhylomeDB; O43819; -.
DR   PathwayCommons; O43819; -.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-9864848; Complex IV assembly.
DR   SignaLink; O43819; -.
DR   SIGNOR; O43819; -.
DR   Agora; ENSG00000284194; -.
DR   BioGRID-ORCS; 9997; 196 hits in 1174 CRISPR screens.
DR   ChiTaRS; SCO2; human.
DR   EvolutionaryTrace; O43819; -.
DR   GeneWiki; SCO2; -.
DR   GenomeRNAi; 9997; -.
DR   Pharos; O43819; Tbio.
DR   PRO; PR:O43819; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; O43819; protein.
DR   Bgee; ENSG00000284194; Expressed in right uterine tube and 176 other cell types or tissues.
DR   ExpressionAtlas; O43819; baseline and differential.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0030016; C:myofibril; IDA:MGI.
DR   GO; GO:0016531; F:copper chaperone activity; IEA:InterPro.
DR   GO; GO:0005507; F:copper ion binding; NAS:UniProtKB.
DR   GO; GO:0015035; F:protein-disulfide reductase activity; IDA:UniProtKB.
DR   GO; GO:0001654; P:eye development; IMP:UniProtKB.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0006878; P:intracellular copper ion homeostasis; IEA:InterPro.
DR   GO; GO:0033617; P:mitochondrial respiratory chain complex IV assembly; IMP:UniProtKB.
DR   GO; GO:0003012; P:muscle system process; IEA:Ensembl.
DR   GO; GO:0022904; P:respiratory electron transport chain; IEA:Ensembl.
DR   GO; GO:0014823; P:response to activity; IEA:Ensembl.
DR   CDD; cd02968; SCO; 1.
DR   FunFam; 3.40.30.10:FF:000013; Blast:Protein SCO1 homolog, mitochondrial; 1.
DR   Gene3D; 3.40.30.10; Glutaredoxin; 1.
DR   InterPro; IPR003782; SCO1/SenC.
DR   InterPro; IPR017276; Synth_of_cyt-c-oxidase_Sco1/2.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   PANTHER; PTHR12151; ELECTRON TRANSPORT PROTIN SCO1/SENC FAMILY MEMBER; 1.
DR   PANTHER; PTHR12151:SF2; PROTEIN SCO2 HOMOLOG, MITOCHONDRIAL; 1.
DR   Pfam; PF02630; SCO1-SenC; 1.
DR   PIRSF; PIRSF037736; SCO1; 1.
DR   SUPFAM; SSF52833; Thioredoxin-like; 1.
DR   PROSITE; PS51352; THIOREDOXIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cardiomyopathy; Chaperone; Copper;
KW   Cytochrome c-type biogenesis; Disease variant; Disulfide bond;
KW   Leigh syndrome; Membrane; Metal-binding; Mitochondrion;
KW   Mitochondrion inner membrane; Primary mitochondrial disease;
KW   Proteomics identification; Reference proteome; Transit peptide;
KW   Transmembrane; Transmembrane helix.
FT   TRANSIT         1..41
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           42..266
FT                   /note="Cytochrome c oxidase assembly factor SCO2"
FT                   /id="PRO_0000031922"
FT   TOPO_DOM        42..60
FT                   /note="Mitochondrial matrix"
FT                   /evidence="ECO:0000305|PubMed:15229189"
FT   TRANSMEM        61..78
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        79..266
FT                   /note="Mitochondrial intermembrane"
FT                   /evidence="ECO:0000305|PubMed:15229189"
FT   DOMAIN          85..259
FT                   /note="Thioredoxin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00691"
FT   BINDING         133
FT                   /ligand="Cu cation"
FT                   /ligand_id="ChEBI:CHEBI:23378"
FT                   /evidence="ECO:0000269|PubMed:17850752,
FT                   ECO:0007744|PDB:2RLI"
FT   BINDING         137
FT                   /ligand="Cu cation"
FT                   /ligand_id="ChEBI:CHEBI:23378"
FT                   /evidence="ECO:0000269|PubMed:17850752,
FT                   ECO:0007744|PDB:2RLI"
FT   BINDING         224
FT                   /ligand="Cu cation"
FT                   /ligand_id="ChEBI:CHEBI:23378"
FT                   /evidence="ECO:0000269|PubMed:17850752,
FT                   ECO:0007744|PDB:2RLI"
FT   DISULFID        133..137
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00691"
FT   VARIANT         20
FT                   /note="R -> P (in dbSNP:rs140523)"
FT                   /evidence="ECO:0000269|PubMed:15461802,
FT                   ECO:0000269|PubMed:19353847"
FT                   /id="VAR_011738"
FT   VARIANT         112
FT                   /note="R -> W (in MYP6; uncertain significance;
FT                   dbSNP:rs370130010)"
FT                   /evidence="ECO:0000269|PubMed:25525168"
FT                   /id="VAR_074010"
FT   VARIANT         114
FT                   /note="R -> H (in MYP6; remains stable in mitochondria;
FT                   reduces the level of the protein copurifying with COA6 by
FT                   80%; dbSNP:rs145100473)"
FT                   /evidence="ECO:0000269|PubMed:23643385,
FT                   ECO:0000269|PubMed:25959673"
FT                   /id="VAR_070053"
FT   VARIANT         120
FT                   /note="R -> W (in MYP6; uncertain significance;
FT                   dbSNP:rs375954523)"
FT                   /evidence="ECO:0000269|PubMed:25525168"
FT                   /id="VAR_074011"
FT   VARIANT         133
FT                   /note="C -> Y (in MC4DN2; dbSNP:rs28937868)"
FT                   /evidence="ECO:0000269|PubMed:14994243"
FT                   /id="VAR_070054"
FT   VARIANT         140
FT                   /note="E -> K (in MC4DN2 and MYP6; reduced cytochrome c
FT                   oxidase subunit II synthesis and reduced ability to
FT                   regulate cellular copper homeostasis; dbSNP:rs74315511)"
FT                   /evidence="ECO:0000269|PubMed:10545952,
FT                   ECO:0000269|PubMed:10749987, ECO:0000269|PubMed:11673586,
FT                   ECO:0000269|PubMed:14994243, ECO:0000269|PubMed:17189203,
FT                   ECO:0000269|PubMed:19336478, ECO:0000269|PubMed:23643385"
FT                   /id="VAR_008874"
FT   VARIANT         171
FT                   /note="R -> W (in MC4DN2; renders the protein unstable;
FT                   dbSNP:rs28937598)"
FT                   /evidence="ECO:0000269|PubMed:10749987,
FT                   ECO:0000269|PubMed:25959673"
FT                   /id="VAR_013238"
FT   VARIANT         193
FT                   /note="G -> S (in MC4DN2; dbSNP:rs759452074)"
FT                   /evidence="ECO:0000269|PubMed:19353847,
FT                   ECO:0000269|PubMed:26741492"
FT                   /id="VAR_076281"
FT   VARIANT         225
FT                   /note="S -> F (in MC4DN2; dbSNP:rs80358232)"
FT                   /evidence="ECO:0000269|PubMed:10545952"
FT                   /id="VAR_008875"
FT   VARIANT         258
FT                   /note="M -> T (in MC4DN2; dbSNP:rs1352878283)"
FT                   /evidence="ECO:0000269|PubMed:26741492"
FT                   /id="VAR_076282"
FT   VARIANT         259
FT                   /note="A -> V (in MYP6; likely benign; dbSNP:rs8139305)"
FT                   /evidence="ECO:0000269|PubMed:23643385"
FT                   /id="VAR_051912"
FT   STRAND          105..108
FT                   /evidence="ECO:0007829|PDB:2RLI"
FT   STRAND          113..115
FT                   /evidence="ECO:0007829|PDB:2RLI"
FT   TURN            116..121
FT                   /evidence="ECO:0007829|PDB:2RLI"
FT   STRAND          122..129
FT                   /evidence="ECO:0007829|PDB:2RLI"
FT   STRAND          134..136
FT                   /evidence="ECO:0007829|PDB:2RLI"
FT   HELIX           137..153
FT                   /evidence="ECO:0007829|PDB:2RLI"
FT   STRAND          160..167
FT                   /evidence="ECO:0007829|PDB:2RLI"
FT   HELIX           174..182
FT                   /evidence="ECO:0007829|PDB:2RLI"
FT   STRAND          190..192
FT                   /evidence="ECO:0007829|PDB:2RLI"
FT   HELIX           195..204
FT                   /evidence="ECO:0007829|PDB:2RLI"
FT   STRAND          227..231
FT                   /evidence="ECO:0007829|PDB:2RLI"
FT   STRAND          237..244
FT                   /evidence="ECO:0007829|PDB:2RLI"
FT   HELIX           247..261
FT                   /evidence="ECO:0007829|PDB:2RLI"
SQ   SEQUENCE   266 AA;  29810 MW;  BC2F40E057329BF3 CRC64;
     MLLLTRSPTA WHRLSQLKPR VLPGTLGGQA LHLRSWLLSR QGPAETGGQG QPQGPGLRTR
     LLITGLFGAG LGGAWLALRA EKERLQQQKR TEALRQAAVG QGDFHLLDHR GRARCKADFR
     GQWVLMYFGF THCPDICPDE LEKLVQVVRQ LEAEPGLPPV QPVFITVDPE RDDVEAMARY
     VQDFHPRLLG LTGSTKQVAQ ASHSYRVYYN AGPKDEDQDY IVDHSIAIYL LNPDGLFTDY
     YGRSRSAEQI SDSVRRHMAA FRSVLS
//
